Gastrointestinal Stromal Tumors (GSTs) Treatment Report

By www.reliablemarketinsights.com

Report Details

Report Name

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size, Status And Forecast 2024-2031 Story

Pages

107

Price

$ 3900

Features

Gastrointestinal Stromal Tumors (GSTs) Treatment Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma